Association between CYP1A2 and CYP1B1 Polymorphisms and Colorectal Cancer Risk: A Meta-AnalysisReport as inadecuate




Association between CYP1A2 and CYP1B1 Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis - Download this document for free, or read online. Document in PDF available to download.

Background

The previous published data on the association between CYP1A2*F rs762551, CYP1B1 Leu432Val rs1056836, Asn453Ser rs180040, and Arg48Gly rs10012 polymorphisms and colorectal cancer risk remained controversial.

Methodology-Principal Findings

The purpose of this study is to evaluate the role of CYP1A2*F, CYP1B1 Leu432Val, Asn453Ser, and Arg48Gly genotypes in colorectal cancer susceptibility. We performed a meta-analysis on all the eligible studies that provided 5,817 cases and 6,544 controls for CYP1A2*F from 13 studies, 9219 cases and 10406 controls for CYP1B1 Leu432Val from 12 studies, 6840 cases and 7761 controls for CYP1B1 Asn453Ser from 8 studies, and 4302 cases and 4791 controls for CYP1B1Arg48Gly from 6 studies. Overall, no significant association was found between CYP1A2*F, CYP1B1 Leu432Val, Asn453Ser, and Arg48Gly and colorectal cancer risk when all the eligible studies were pooled into the meta-analysis. And in the subgroup by ethnicity and source of controls, no evidence of significant association was observed in any subgroup analysis.

Conclusions-Significance

In summary, this meta-analysis indicates that CYP1A2*F, CYP1B1 Leu432Val, Asn453Ser, and Arg48Gly polymorphisms do not support an association with colorectal cancer, and further studies are needed to investigate the association. In addition, our work also points out the importance of new studies for CYP1A2*F polymorphism in Asians, because high heterogeneity was found dominant model: I2 = 81.3%; heterozygote model: I2 = 79.0.



Author: Xiao-Feng He , Jie Wei , Zhi-Zhong Liu, Jian-Jun Xie, Wei Wang, Ya-Ping Du, Yu Chen, Hui-Qiang Si, Qing Liu, Li-Xia Wu, Wu Wei

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents